health Bimekizumab Shows 3-Year Psoriasis Symptom and Quality of Life Improvements
Three-year data from the BE RADIANT trial confirm bimekizumab's sustained effectiveness in treating moderate-to-severe plaque psoriasis, significantly improving patient-reported symptoms and quality of life.
